chronic pain/cannabis

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 408 rezilta yo

Cannabis for the Treatment of Chronic Pain in the Era of an Opioid Epidemic: A Symposium-Based Review of Sociomedical Science.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

UNASSIGNED This manuscript reviews medical literature published pertaining to the management of chronic pain with medical marijuana therapy (MMJ), with an emphasis on the social, medical, and legal aspects of therapy. UNASSIGNED Narrative review of peer-reviewed literature. UNASSIGNED The 3rd

Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The misuse of prescription opiates is on the rise with combination therapies (e.g. acetaminophen or NSAIDs) resulting in severe liver and kidney damage. In recent years, cannabinoid receptors have been identified as potential modulators of pain and rewarding behaviors associated with cocaine,

Medical cannabis and cognitive performance in middle to old adults treated for chronic pain

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Introduction and aims: Cannabis exposure is becoming more common in older age but little is known about how it is associated with brain health in this population. This study assesses the relationship between long-term medical cannabis

Medical Cannabis for the Treatment of Chronic Pain: A Review of Clinical Effectiveness and Guidelines

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Chronic pain is defined as pain that persists for more than three months.¹ It may present as headache, musculoskeletal pain, visceral pain, neuropathic pain, pain arising from rheumatic disease, and cancer pain.¹ Chronic pain is a global problem.² In Canada,

Cannabis Use in Hospitalized Patients with Chronic Pain

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Introduction: To date, no study has reported the prevalence of cannabis use in chronic pain patients. The aim of this study is to investigate the trends in cannabis use among chronic pain in-patients from 2011 to 2015 in the USA.

Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Choosing an appropriate treatment for chronic pain remains problematic, and despite the available medication for its treatment, still, many patients complain about pain and appeal to the use of cannabis derivatives for pain control. However, few data have been provided to clinicians about the

[Evidence of the efficacy and safety of cannabis medicines for chronic pain management : A methodological minefield].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Recent systematic reviews (SRs) came to divergent conclusions on the efficacy and safety of medical marijuana and cannabis-based medicines for chronic pain management. This paper gives an overview and critical appraisal of the methods of recent SRs of randomized controlled trials (RCTs) with

[MEDICAL MARIJUANA DEPENDENCE AMONG CHRONIC PAIN PATIENTS SUFFERING FROM DEPRESSION AND ANXIETY].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In recent years, medical marijuana (MM) is increasingly being used for the treatment of chronic pain. Depression and anxiety have been identified as risk factors for the problematic use of prescription opioids, yet their contribution to developing MM dependence hasn't been explored up

Cannabis-based medicines for chronic pain management: current and future prospects.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The medicinal use of cannabis has recently become the focus of much medical, as well as political, attention. This reality of growing use but limited evidence creates unique dilemmas for the prescribing clinician. The purpose of this review is to explore current evidence and gaps in

The Association Between Cannabis Use and Aberrant Behaviors During Chronic Opioid Therapy for Chronic Pain.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

UNASSIGNED Health care providers are likely to see an increase in the concomitant use of cannabis and opioids, particularly with the increased liberalization and ongoing research into the possible role of medical marijuana for chronic pain. Recent literature reports a prevalence of concurrent use

Cannabinoids in the management of chronic pain: a front line clinical perspective.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Chronic pain is an escalating public health problem. Currently available treatments are inadequate to control chronic pain conditions, and there is a critical need for novel treatments. Over a half century of elegant preclinical research has identified the presence of a sophisticated endocannabinoid

Disagreement and Uncertainty Among Experts About how to Respond to Marijuana Use in Patients on Long-term Opioids for Chronic Pain: Results of a Delphi Study.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Marijuana use is common among patients on long-term opioid therapy (LTOT) for chronic pain, but there is a lack of evidence to guide clinicians' response.To generate expert consensus about responding to marijuana use among patients on

The Interaction of Alcohol Use and Cannabis Use Problems in Relation to Opioid Misuse Among Adults with Chronic Pain.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The opioid epidemic is a significant public health crisis and prescription opioids are often used to manage chronic pain, despite questionable long-term efficacy. Furthermore, co-substance (mis)use is also common among individuals with chronic pain who use opioids. Alcohol has been

Use of ketamine for acute suicidal ideation in a patient with chronic pain on prescribed cannabinoids.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Ketamine is a standard anaesthetic drug that has been studied as a possible treatment for acute suicidal ideation. Aside to the potential psychotropic effects of ketamine, a Cochrane review reported that available studies suggest a modest effect of ketamine for chronic pain months to years after

Guidelines for the use of cannabinoid compounds in chronic pain.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To provide clinicians with guidelines for the use of cannabinoid compounds in the treatment of chronic pain. METHODS Publications indexed from 1990 to 2005 in the National Library of Medicine Index Medicus were searched through PubMed. A consensus concerning these guidelines was achieved

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye